Triple probe FISH approach for detecting EML4-ALK gene rearrangement in Chinese patients with NSCLC

被引：0
|
作者：
Mao, Weimin
Han, Mark
Ling, Zhiqiang
Sun, Wenyong
Zhang, Gu
Dong, Hongshan
Zhang, Yingzi
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[2] GeneDiagnost Inc, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21080
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant
    To, Ka-Fai
    Tong, Joanna H. M.
    Yeung, King S. F.
    Lung, Raymond W. M.
    Law, Peggy P. Y.
    Chau, Shuk Ling
    Kang, Wei
    Tong, Carol Y. K.
    Chow, Chit
    Chan, Anthony W. H.
    Leung, Linda K. S.
    Mok, Tony S. K.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 883 - 891
  • [32] Discovery and Development of Lorlatinib: A Macrocyclic Inhibitor of EML4-ALK for the Treatment of NSCLC
    Dugger R.
    Li B.
    Richardson P.
    ACS Symposium Series, 2019, 1332 : 27 - 59
  • [33] Analysis of EML4-ALK fusion transcripts in plasma and platelets to monitor response to crizotinib in EML4-ALK positive non-small cell lung cancer patients (NSCLC)
    Aguado, Cristina
    Teixido, Cristina
    Gimenez-Capitan, Ana
    Gil, Maria de los Llanos
    Rodriguez, Sonia
    Viteri, Santiago
    Karachaliou, Niki
    Aldeguer, Erika
    Peg, Vicente
    Alonso, Lidia
    Molina-Vila, Miguel Angel
    Rosell, Rafael
    CANCER RESEARCH, 2017, 77
  • [34] Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system
    Li, Siwen
    Liu, Yuxi
    Rui, Yalan
    Tang, Liping
    Achilefu, Samuel
    Gu, Yueqing
    THERANOSTICS, 2018, 8 (10): : 2621 - 2633
  • [35] EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer
    Wang, Zhijie
    Zhang, Xuchao
    Bai, Hua
    Zhao, Jun
    Zhuo, Minglei
    An, Tongtong
    Duan, Jianchun
    Yang, Lu
    Wu, Meina
    Wang, Shuhang
    Wang, Yuyan
    Wu, Yilong
    Wang, Jie
    ONCOLOGY, 2012, 83 (05) : 248 - 256
  • [36] EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder
    Alexander, Riley E.
    Montironi, Rodolfo
    Lopez-Beltran, Antonio
    Williamson, Sean R.
    Wang, Mingsheng
    Post, Kristin M.
    Sen, Joyashree D.
    Arnold, Ashley K.
    Zhang, Shaobo
    Wang, Xiaoyan
    Koch, Michael O.
    Hahn, Noah M.
    Masterson, Timothy A.
    MacLennan, Gregory T.
    Davidson, Darrell D.
    Comperat, Eva
    Cheng, Liang
    MODERN PATHOLOGY, 2014, 27 (01) : 107 - 112
  • [37] EML4-ALK FUSION GENE IN LUNG ADENOCARCINOMA IN THAILAND
    Prempree, Thongbliew
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1023 - S1024
  • [38] Clinical diagnosis of EML4-ALK mutation in NSCLC by a gold nanoparticle beacon
    Liu, Yuxi
    Li, Siwen
    Chen, Dan
    Wang, Zhaohui
    Zhang, Jinnan
    Tian, Caiping
    Ding, Li
    Chen, Yaqi
    Qian, Zhiyu
    Gu, Yueqing
    RSC ADVANCES, 2016, 6 (104) : 102398 - 102405
  • [39] EML4-ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors
    Vargas-Madueno, Fernando
    Gould, Edwin
    Valor, Raul
    Ngo, Nhu
    Zhang, Linsheng
    Villalona-Calero, Miguel A.
    ONCOLOGIST, 2018, 23 (10): : 1127 - 1132
  • [40] Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue
    Ulivi, Paola
    Puccetti, Maurizio
    Capelli, Laura
    Chiadini, Elisa
    Bravaccini, Sara
    Calistri, Daniele
    Zoli, Wainer
    Amadori, Dino
    Candoli, Piero
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (08) : 708 - 710
12345